.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Teva
Deloitte
Boehringer Ingelheim
Argus Health
Fuji
McKesson
Farmers Insurance
Merck
Federal Trade Commission

Generated: June 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018896

« Back to Dashboard
NDA 018896 describes POTASSIUM ACETATE, which is a drug marketed by Exela Pharma Scs Llc and Hospira and is included in two NDAs. It is available from two suppliers. Additional details are available on the POTASSIUM ACETATE profile page.

The generic ingredient in POTASSIUM ACETATE is potassium acetate. There are two hundred and twenty-seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the potassium acetate profile page.

Summary for NDA: 018896

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Therapeutic Nutrients/Minerals/Electrolytes
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 018896

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
POTASSIUM ACETATE
potassium acetate
INJECTABLE;INJECTION 018896 NDA Hospira, Inc. 0409-3294 0409-3294-25 25 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (0409-3294-25) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE
POTASSIUM ACETATE
potassium acetate
INJECTABLE;INJECTION 018896 NDA Hospira, Inc. 0409-3294 0409-3294-51 25 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (0409-3294-51) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength2MEQ/ML
Approval Date:Jul 20, 1984TE:APRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Citi
Colorcon
Argus Health
Harvard Business School
QuintilesIMS
McKesson
Accenture
UBS
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot